Fubotv earnings beat by $0.10, revenue topped estimates
Cathie Wood’s ARK ETFs have made significant moves in the stock market on Wednesday, 16 July 2025, with notable transactions across a range of sectors. The daily trade report revealed a strategic bolstering of positions in certain high-tech and biotech companies, while reducing holdings in others.
The most substantial purchase of the day was the acquisition of 600,000 shares of the 3IQ ETHER STAKING ETF (ETHQ.U), divided equally between the ARKW and ARKF ETFs, with a combined dollar value of $7,164,000. This move underscores ARK’s continued interest in the cryptocurrency sector, despite the volatility often associated with these assets.
Following closely was ARK’s investment in Tempus AI Inc (TEM), where the firm bought 158,051 shares across its ARKK and ARKG ETFs, totaling $8,833,470. This purchase continues a recent trend of ARK increasing its stake in Tempus AI, suggesting a strong conviction in the company’s potential in the artificial intelligence and healthcare space.
In the semiconductor sector, ARK showed confidence by purchasing 11,021 shares of NVIDIA Corp (NASDAQ:NVDA) through its ARKX (NYSE:ARKX) ETF, totaling $1,881,284. NVIDIA’s position in the AI and gaming markets likely makes it an attractive long-term play for ARK’s innovation-focused strategy.
Another notable buy included 12,237 shares of Iridium Communications Inc (NASDAQ:IRDM) through the ARKX ETF, with a total value of $384,731. This investment aligns with ARK’s focus on space exploration and satellite communication technologies.
On the sell side, ARK made a significant divestment from Roku Inc (NASDAQ:ROKU), offloading a total of 194,433 shares across three of its ETFs (ARKK, ARKW, ARKF), amounting to a hefty $17,358,978. This sale marks a continuation of ARK’s recent trend of reducing its exposure to the streaming device company.
Other sales included 53,932 shares of Adaptive Biotechnologies Corp (NASDAQ:ADPT) for $596,487, 21,712 shares of Guardant Health Inc (NASDAQ:GH) for $1,044,130, and 57,567 shares of Rocket Lab USA Inc (NASDAQ:RKLB) for $2,567,488, reflecting a strategic shift in ARK’s biotech and aerospace holdings.
Cathie Wood’s ARK ETFs are known for their active management and focus on disruptive innovation. The latest trades suggest a continued emphasis on companies poised for growth in the fields of AI, healthcare, and space exploration, while carefully adjusting positions in response to market dynamics and portfolio strategy. Investors following ARK’s movements will be watching closely to see how these trades play out in the ever-evolving landscape of the technology and biotech sectors.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.